Cetuximab Antibody (2259C) [Phycoerythrin]

A431 cells were stained with Human Anti-Human EGFR (Research Grade Cetuximab Biosimilar) Monoclonal Antibody (MAB9577, filled histogram) or isotype control antibody (1-001-A, open histogram), followed by Rabbit Anti-Cetuximab (Anti-Idiotype) PE monoclonal antibody (Catalog # FAB9626P). View our protocol for Staining Membrane-associated Proteins.

• Reactivity: All-Multi
• Applications: Flow
• Clone: 2259C
• Clonality: Monoclonal
• Host: Rabbit
• Conjugate: Phycoerythrin

Cetuximab Antibody (2259C) [Phycoerythrin] Summary

• Additional Information: Recombinant Monoclonal Antibody.
• Immunogen: Full length Cetuximab
• Specificity: Detects Cetuximab in Western blots and direct ELISAs. No cross-reactivity with Adalimumab, Rituximab, Trastuzumab, Brentuximab, Gemtuzumab, Ibritumomab, Tositumomab, Solanezumab, Teprotumumab, and Aducanumab is observed.
• Source: N/A
• Isotype: IgG
• Clonality: Monoclonal
• Host: Rabbit
• Purity Statement: Protein A or G purified from cell culture supernatant

Applications/Dilutions

• Dilutions:
  • Flow Cytometry
• Application Notes: Optimal dilution of this antibody should be experimentally determined.

Packaging, Storage & Formulations

• Storage: Protect from light. Do not freeze.
  • 12 months from date of receipt, 2 to 8 °C as supplied.
• Buffer: Supplied 0.2 mg/mL in a saline solution containing BSA and Sodium Azide.
• Preservative: 0.05% Sodium Azide

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Cetuximab Antibody (2259C) [Phycoerythrin]

• Cetuximab

Background

The anti-Cetuximab antibody is an anti-Idiotype antibody raised against and selected for the antigenic determinants of the variable region of Cetuximab. The antibody has been tested against a broad range of other biosimilars to ensure specificity. This highly specialized anti-idiotypic antibody can be used in a variety of pharmacokinetic (PK) assay formats.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.